Congenital heart defects
are the most common birth defects in the world1-2.
1.35 million babies worldwide are born with congenital heart disease every year1-2.
Nearly 25 % of babies with a congenital heart defect require surgery during their first year3.
93 % of these children have no access to care2-4.
An initiative to support children with congenital heart defects.
As a global healthcare company, Abbott is committed to research and development of life-changing technologies for babies and children with heart problems. We partner with organizations and physicians dedicated to giving these children the best possible treatment.
And to give them the chance to grow up and reach their full potential.
“It’s part of our commitment to provide physicians with everything they need to give all their patients the very best standard of care,” says Mike Dale, Vice President of Abbott’s Structural Heart business.
CONTACT US
If you have any questions or comments about this website, please address them to: info@ little-heartheroes.com
References
1. Van der Linde S., Birth Prevalence of Congenital Heart Disease Worldwide. A Systematic Review and Meta-Analysis, J Am Coll Cardiol 2011;58:2241–7
2. Hoffmann J., The global burden of congenital heart diseaseCardiovasc J Afr 2013; 24: 141–145
3. Moller JH, Taubert KA, Allen HD, Clark EB, Lauer RM. Cardiovascular health and disease in children: current status. A Special Writing Group from the Task Force on Children and Youth, American Heart Association. Circulation. 1994;89(2):923-930.
4. The Heart Fund Manifesto 2015